Suppr超能文献

感染性休克患者中去甲肾上腺素的早期与延迟给药

Early versus delayed administration of norepinephrine in patients with septic shock.

作者信息

Bai Xiaowu, Yu Wenkui, Ji Wu, Lin Zhiliang, Tan Shanjun, Duan Kaipeng, Dong Yi, Xu Lin, Li Ning

出版信息

Crit Care. 2014 Oct 3;18(5):532. doi: 10.1186/s13054-014-0532-y.

Abstract

INTRODUCTION

This study investigated the incidence of delayed norepinephrine administration following the onset of septic shock and its effect on hospital mortality.

METHODS

We conducted a retrospective cohort study using data from 213 adult septic shock patients treated at two general surgical intensive care units of a tertiary care hospital over a two year period. The primary outcome was 28-day mortality.

RESULTS

The 28-day mortality was 37.6% overall. Among the 213 patients, a strong relationship between delayed initial norepinephrine administration and 28-day mortality was noted. The average time to initial norepinephrine administration was 3.1 ± 2.5 hours. Every 1-hour delay in norepinephrine initiation during the first 6 hours after septic shock onset was associated with a 5.3% increase in mortality. Twenty-eight day mortality rates were significantly higher when norepinephrine administration was started more than or equal to 2 hours after septic shock onset (Late-NE) compared to less than 2 hours (Early-NE). Mean arterial pressures at 1, 2, 4, and 6 hours after septic shock onset were significantly higher and serum lactate levels at 2, 4, 6, and 8 hours were significantly lower in the Early-NE than the Late-NE group. The duration of hypotension and norepinephrine administration was significantly shorter and the quantity of norepinephrine administered in a 24-hour period was significantly less for the Early-NE group compared to the Late-NE group. The time to initial antimicrobial treatment was not significantly different between the Early-NE and Late-NE groups.

CONCLUSION

Our results show that early administration of norepinephrine in septic shock patients is associated with an increased survival rate.

摘要

引言

本研究调查了感染性休克发作后去甲肾上腺素延迟给药的发生率及其对医院死亡率的影响。

方法

我们进行了一项回顾性队列研究,使用了一家三级医院的两个普通外科重症监护病房在两年期间治疗的213例成人感染性休克患者的数据。主要结局是28天死亡率。

结果

总体28天死亡率为37.6%。在213例患者中,观察到初始去甲肾上腺素延迟给药与28天死亡率之间存在密切关系。初始去甲肾上腺素给药的平均时间为3.1±2.5小时。感染性休克发作后的前6小时内,去甲肾上腺素起始每延迟1小时,死亡率增加5.3%。与感染性休克发作后少于2小时开始去甲肾上腺素给药(早期去甲肾上腺素组)相比,感染性休克发作后2小时及以上开始去甲肾上腺素给药(晚期去甲肾上腺素组)时,28天死亡率显著更高。早期去甲肾上腺素组感染性休克发作后1、2、4和6小时的平均动脉压显著更高,而2、4、6和8小时的血清乳酸水平显著低于晚期去甲肾上腺素组。与晚期去甲肾上腺素组相比,早期去甲肾上腺素组的低血压持续时间和去甲肾上腺素给药持续时间显著更短,24小时内去甲肾上腺素给药量显著更少。早期去甲肾上腺素组和晚期去甲肾上腺素组之间初始抗菌治疗时间无显著差异。

结论

我们的结果表明,感染性休克患者早期给予去甲肾上腺素与生存率增加相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f8b/4194405/39b8c178a97a/13054_2014_532_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验